With the explosion in new technologies that heralded the end of the 20th century, enabling the rapid gathering and analysis of genetic information from humans and the multitude of other organisms with which they interact on this planet, we are now in a position not only to understand the details of everyone's genetically determined features, but to manipulate them to our own design. The implications of the power of such knowledge are indeed profound, demanding that the developers and users of the technology spawned by this revolution apply it according to the terms of a new social contract to be negotiated with the public at large. The means by which industries and medical practitioners educate the public consumers, and the mechanisms by which the public, through the institutions of democratic government and other modes of communication, makes its concerns and desires a functional part of the equation, are being determined. To establish processes for both, with the flexibility to accommodate individual and collective values that are highly time-dependent, is a major challenge of the 21st century. Applications of genetic data are examined with respect to professional responsibility, the possibility of deliberate misuse, the principle of autonomy, and distributive justice.
The worldwide initiative to obtain the entire base sequence of the human genome, as well as those of selected other organisms, and especially those of the microbes that cause our diseases, is well under way. While estimates vary with respect to the date when we will have a detailed genetic map of the human organism, including identification of those regions of the genome (about 0.1 per cent) that are variable among individuals and thus account for the multitude of differences between us, all agree that the date is not far away-perhaps by 2005 at the latest. The date by which we will have assigned the proper function to the complete set of genes so described is probably not far behind-10 or 20 years from now at the most. But the exact date-soon by any reckoning-by which the goals will inevitably be reached is unimportant in comparison with the ultimate implications of the project.
In this discussion, I am including the entire amalgamation of global efforts to obtain human and non-human DNA base sequence data and genetic maps, both those efforts under the aegis of publicly funded programs such as the Human Genome Project (HGP) sponsored by the National Institutes of Health in the United States, the HUGO program, a coordinated effort centered in Europe to allocate tasks and collect and analyze data, and numerous private and commercially financed initiatives, conducted by the growing number of genomics companies. Indeed, the information gained will be available worldwide (except perhaps for some genetic data that certain companies prefer to keep as trade secrets), and the consequences of the uses of detailed genetic information will affect the entire planet. While there are a few issues that are limited to specific global regions where the idiosyncrasies of the cultural, political, or social welfare systems create unique local issues (such as the for-profit health insurance and healthcare systems in the United States), the overriding matters of professional responsibility and public concerns are universal.
It is not the purpose of this essay to describe the scientific and technical specifics of the endeavor, which are described extensively elsewhere.
What does it all mean?
It is useful at this point to look briefly at the implications of the immense body of knowledge to be gained from this collective effort, and the array of potential applications that will be enabled by such knowledge. To be sure, as the horizons of our knowledge and understanding of life seem to expand continuously, with no limit in sight, we cannot anticipate all of the corollaries of the information we are gathering, nor the torque such knowledge may exert upon social institutions. Nevertheless, looking into the future as far as we dare to, there are many outcomes that we can be rather sure about. The four following categories of information, admittedly rather loosely defined, represent, in order of increasing capacity to affect human life, types of applications of genetic information that carry with them an implied responsibility and public accountability for those promoting their use. At the same time, they represent issues for which the public, who constitute the users of such information and the applications spawned by it, will have an increasing number of questions, concerns and fears. These categories are:
1. Detailed information on the genomic structure of numerous infectious agents, as well as much new data on the human immune system, are already allowing us to understand the nature of the pathology of disease much better, enabling the design of much safer and more effective vaccines, immune modulators, and new classes of pharmaceuticals for the prevention and treatment of the full array of human infectious pathology. 2. A detailed knowledge of the human genome will permit a precise definition not only of overt inborn errors-that is, the so-called genetic diseases-but allow an assessment of a particular individual's susceptibility to or capacity to avoid many types of disorders, including infectious diseases. Not only will such information make the art of genetic counseling much more complex than it is today, but it will also lead to a much greater variety of effective interventions. In particular, targeted gene therapy for a wide variety of disorders will become possible. 3. Both pre-embryo genetic diagnosis and selection, and human germline therapy, performed on a zygote at the time of fertilization, will become feasible forms of reproductive intervention, to eliminate the possibility of children being born with genetic pathology, or even carrying unexpressed or recessive genetic errors. 4. Detailed genetic information, when it finally becomes correlated with function, will permit a comprehensive understanding of an individual's physical, cognitive, and behavioral traits (including how gene expression during development will be influenced by the environment). While such information would reveal the basis for much current or future pathology, it would also reveal subclinical or non-clinical tendencies or characteristics that all contribute to the total human being. It is highly likely that this will include predictors of not only physical attributes, such as stature, body type, and athletic ability, but personality, intellect, musical and artistic talent, and perhaps even moral character.
Professional responsibility and public accountability
Does understanding the details of our own genetic make up really pose any unique challenges to professional responsibility and corporate accountability, which the limitations in our knowledge and technology made unnecessary at an earlier time? Does the explosion in current genetic information and understanding pose any truly new or unprecedented ethical issues? Are there issues that need to be dealt with in novel ways, for which the policy-making systems in place in at least most democratic societies are inadequate? For issues of such increasing complexity, it is important to explore the boundary between the responsibility of the professional and the duty of society, through its legal and policy-making mechanisms, to set guidelines, and promote or regulate the use of such technologies and information in the "public interest." In the first category defined above, that of the design, production, and delivery of new pharmaceuticals and biologicals, and strategies of medical intervention based on what may at this point be revolutionary concepts in infectious disease (e.g. the discovery of prions, as the agent of Creutzfeldt-Jacob syndrome, and no doubt other disorders, or that bacterial infections are ultimately responsible for peptic ulcers, atherosclerosis, and many other chronic conditions), the industries and medical practitioners developing and promoting the use of such new strategies have, of course, a particular responsibility to benefit the patient/user, at least to an extent exceeding any potential harm that may be done. From the Hippocratic oath to the present-day regulation of the medical profession and the pharmaceutical industry, this set of novel applications of genetic information is already subject to numerous instances of institutionalized and standardized public accountability. New drugs and vaccines, whether or not based directly on human or non-human genomic data, are subject to all of the same rules and standards that now prevail with regard to the pharmaceutical and biological industries to ensure the public that consumers are provided with safe and efficacious products. It is a process mediated by regulatory agencies like the U.S. Food and Drug Administration (FDA) to be sure proper and uniform standards of safety and efficacy are in fact observed.
Among the first novel applications of detailed genetic data to the practice of medicine will be the development of the means to obtain a comprehensive genetic map of an individual (category 2 above). As the techniques for genetic analysis become faster and totally automated, the database that can be generated by such screening will eventually encompass all human genes. The data obtained will eventually identify for each individual numerous predictors of future health status, as well as dictate exactly what, if any, interventions are appropriate for the correction or treatment of any particular genetic pathology. Thus the means for detailed routine genetic screening, perhaps at birth, or in the early stages of gestation, will soon be available.
It can be safely anticipated that one class of products to be generated by such genetic data would be a set of somatic gene therapy vectors, for the treatment of at least those disorders that are amenable to such an approach. Again, such intervention must meet accepted standards of safety and efficacy. Gene therapy can be expected to become routine for an increasing number of the more accessible disorders. The attention, and concomitant worries, attracted by the novelty of the first wave of such interventions over the past decade, have largely dissipated.
The vast increase in the amount of prenatal genetic information potentially available as well as the proliferation of new gene therapies makes the role of the genetic counselor necessarily one of increasing complexity and difficulty. The body of data that one will, in principle, be able to obtain, along with the prediction of overt pathology, subclinical pathology, and simply reduced functionality (e.g. a low level of an essential enzyme), will increase steadily. At the present time, prospective parents are given hard choices, for example, in facing a 50 per cent chance of having a child with severe and fatal muscular dystrophy, or Huntington's disease that will not manifest itself until middle age. Analysis of fetal DNA obtained through amniocentesis establishes with certainty the phenotype with respect to problem alleles carried by its parents. The practitioner's responsibility is generally limited to providing (1) accurate information concerning the genetic defect and what this means to the person afflicted, and (2) only that which is requested by the patient/user. The genetic counselor describes alternative courses of action, but the choice to be made (e.g. abortion) is left to the parents. This must be so in any society that respects the autonomy of the individual, especially with respect to reproductive rights. Most genetic counselors are careful not to exert paternalistic coercion on their advisees, but subtle pressure no doubt does occur often.
However, the sheer quantity of data soon to be made possible may pose a kind of information overload on the decision-making capacities of the user, already faced with difficult choices under the simplest of circumstances (e.g. when the parents each carry a simple Mendelian recessive trait). While it is true that the number of diagnosable disorders that can be treated or prevented will continue to increase, there will always be a subset of problems that, by the time diagnosis is made, cannot be corrected. There is also the possibility that selective abortion may be exercised more often even on the basis of factors that may be rather mild treatable disorders or even traits that parents would prefer that their child did not have. The application of selective abortion simply on the basis of the sex of the child is controversial in most of the West, and has already resulted in a significant skewing of the sex ratio among young Chinese. However, in spite of pressure from the Catholic Church and religious Right in the United States to proscribe abortion, the weight given to individual autonomy in personal reproductive choice remains the dominant ethical criterion in most countries, a fact which becomes very relevant, as we shall see with respect to germline intervention and enhancement therapies.
When the situation falls into the third category defined above, where direct reproductive intervention is the only way to ensure a healthy baby, then the medical profession is charting new territory, where there are no precedents or standards, institutionalized or otherwise. Preimplantation screening is just coming into use on a limited basis, and germline therapy
1 is yet to be attempted. There will, of course, be a first time. No doubt, the kinds of safeguards that will be required, as in most new procedures being tried without a body of clinical data to give the physician or geneticist the assurance that it will probably work out as expected, will be very stringent at first, to be relaxed only when the procedures are proven to be highly reliable. The nature of the proof required to demonstrate that a particular germline modification is not only risk-free to the individual recipient but also to subsequent generations is obviously much more complex than when the intervention ends with the patient. To make such a judgment, it will probably be necessary to demonstrate that the correction made was precisely at its original genetic location, and that genetic material has not been added in a place where it does not normally occur, making its fate uncertain. In any case, again consistent with the value placed on individual autonomy in other medical interventions, the ultimate choice must lie with the prospective parents.
However, just as safety in any medical technology is a prerequisite for its use, it has long been an accepted cornerstone of medical responsibility that the physician shall use whatever means are available to prevent and treat pathology in his patients. The "patient", in view of the increased scope of possible intervention, must now be defined broadly to include not only an unborn child, but also the potential human created by the event of fertilization. Therefore, it can be argued that the exercise of professional responsibility would require the physician to use germline therapy, if it were the only means to avert a genetic disorder-it would be unethical not to do so.
The fourth category above includes applications of detailed genetic information that represent a departure from what is considered medical practice (i.e. aimed at the prevention or correction of pathology), and to exercise control or choice over what traits to incorporate into a human-to-be. From the perspective of professional responsibility (as opposed to public fears or societal implications, to be discussed later), it is first essential that the intervention will do exactly what it is supposed to do. Stringent standards of safety, including avoiding the introduction of iatrogenic genetic errors, will be essential, and the genome of the resultant modified zygote must be checked to be sure that it has the desired genetic configuration. But do professionals have a responsibility that exceeds ensuring technical accuracy and safety, and improving the physical or mental health of the patient? Should the professional expert refuse to accede to the wishes of a client? To be sure, just as a doctor may refuse to alter the fingerprints of a criminal or a plastic or cosmetic surgeon may refuse to perform a radical reshaping of an individual who may request it, so may the gene doctor. That is, while the physician has an acknowledged and accepted responsibility to treat patients who are, or who may become "ill", there is no such precedent that requires a physician to accede to a request for improving the individual. Actually, in this discussion, while we use the term "physician", we should recognize what will someday constitute a new category of specialist-the expert in human cell biology and genetics who can construct an embryo with specific genetic alterations.
The possibility of enhancing the phenotype of a human-to-be using targeted germline genetic intervention has received attention from both the scientists developing intervention technologies and bioethicists. Assuming that the genetic information and state of the technology will advance sufficiently to permit a reliable, low-risk intervention procedure to be performed, the possibility of its use has, nevertheless, at least up to the present, generally been judged as being inappropriate under any circumstances. Times, however, change, as do the standards of what is appropriate and acceptable and what is not. One can, therefore, expect that in time, and especially in the face of eventual technical accuracy, safety, and predictability of such enhancement intervention, there will very likely be a significant demand for such services and professionals willing and able to perform them. Given the likelihood of procedures that perhaps fall in some ways into the same sphere as other enhancement procedures (cosmetic surgery), one may expect guidelines or standards to be set by professional organizations and licensing boards to ensure that a uniform degree of responsibility and accountability is met by all of their members. As now, there may always be the odd one who is willing to perform very radical interventions with questionable benefits; setting limits to what is reasonable and appropriate professional conduct may therefore be called for. However, there is also the risk that such guidelines could become needlessly restrictive as social mores and standards change, and especially at the point where civil rights and autonomy are in danger of being abridged.
An additional point, and one that is particularly relevant in litigious societies like the United States, is how the underwriters of malpractice insurance are going to deal with the opening of a whole universe of genetic enhancement procedures. No physician-or gene doctor-is going to risk being sued if something goes unexpectedly wrong, especially without ample insurance to cover even the rare mishap. In the current practice of medicine, physician error is not a particularly rare occurrence, all physicians have malpractice insurance, and the litigation of malpractice suits has become a cottage industry. However, in the application of a radically new technology, particularly where its use is not essential to ensure the physical health of the patient, something very close to perfection is likely to be expected by the users and demanded of the professional. This prospect alone could be a great deterrent to the widespread use of enhancement procedures, at least until such time that a body of data were accumulated proving the high reliability of the methods and coverage of the practitioner by malpractice or liability insurance.
While we recognize the importance of individual autonomy and the right to decide, within limits, the fate of one's own body, professional responsibility must take into account the fact that any such enhancement at the germline level will be passed to the descendants of the individual so created. Obviously a modified embryo, if afforded the status of an individual human being with all accompanying rights, cannot argue on behalf of itself or its descendants. To what degree then is the accepted norm that parents are expected to do the best they can for their children applicable to such a situation? And does the gene doctor have to accept that a decision of the prospective parents-to-be that the alterations they wish to have done are in their child's (and its descendant's) best interests? Does the professional expert have a responsibility to assist the parents realize their decision to "help" their child, if the technical means are available to do so? As in other requests for enhancement, using techniques now available, the professional clearly has the responsibility to exercise sound judgment, and not simply be bound by a request from a client. The fact that the procedure may affect generations, however, makes the exercise of that responsibility far more onerous. So much so, that it is doubtful that many would wish to assume it.
Arguments claiming that germline intervention, to correct clearly defective genes, or to "trade-up" to more desirable alleles would significantly alter the gene pool are generally unsupportable. However, if the number of certain very rare but highly valued alleles were increased significantly (e.g. a hypothetical "genius" gene), then a relatively small number of enhancement interventions could alter the gene pool ratios significantly. But is that such an undesirable thing? Few would disagree that the traits to be incorporated by the enhancers would be generally valued as desirable by a vast majority of the population. Hence, would a professional be abrogating his or her responsibility to the consumer by enabling the use and practice of enhancement intervention? On the contrary, many would very likely argue that by increasing the number of desirable genes in an individual, they are improving the gene pool, and are therefore acting in a very socially responsible manner.
The question of fairness, that is, the availability of enhancement technology to all those who wish it, regardless of the ability to pay (it is likely to be very expensive when it first becomes available) is also an important issue, not unlike the current question of equanimity and distributive justice in the availability of current healthcare technologies, and especially those considered heroic and/or very expensive. Traditionally, the issue does not really fall within the realm of professional responsibility, or become the burden of those providing the technology or the services. It is rather a subject for the institutions that set social policies. However, as we have seen in the United States with respect to distributive justice in the delivery of healthcare, it can become hopelessly mired in partisan politics and pressure from powerful "vested interests," like the insurance companies and for-profit managed healthcare companies. Sometimes lobbying by patient groups (part of the "public", to be sure), can result in specific programs, such as the renal dialysis program in the United States, created by an act of Congress, which provides dialysis for all patients who require it. In general, however, the extent and quality of healthcare clearly improves in most parts of the world with one's ability to pay, and this is especially true of intervention where the patient is not at high risk.
Public concerns
Before examining the kinds of concerns that have surfaced concerning both the availability of genetic data on an unprecedented scale and the many new doors of both science and technology that such information will allow to be opened, it is important to look briefly at the public perceptions of science and technology generally. First of all, it is essential to emphasize once again the fundamental distinction between science, the search for the truth, and technology, the multitude of uses to which scientific knowledge may be put. Knowledge per se is devoid of ethical content or moral value. It simply is. The uses of knowledge and understanding, and even of pure information may be deemed by society as good or bad (or both) depending on the social, historical, and cultural context, and on the prevailing human and social values of the times.
DDT, for example, was universally considered to be very good in 1940s when its widespread use succeeded in greatly reducing the incidence of many insect-borne human diseases and the chronic destruction due to agricultural pests. A quarter of a century later, when the ecological devastation of DDT became known, DDT was a mixed blessing. Now, more than 50 years after its initial use, DDT is banned for use nearly everywhere. The twentieth century is replete with numerous examples of how the ethical values of numerous applications of knowledge have fluctuated with the times-x-rays, nuclear fission, tonsillectomy, tranquilizers, fluorocarbon refrigerants, spray paint, and gene splicing. These examples illustrate rather poignantly that the value content of technology, whether that placed by the developers and promoters, the users, or the public in general, depends ultimately on the availability of complete and accurate information.
There are three common grounds (among many others) for why there is public controversy over the spectrum of new technologies, and specifically over applications spawned by the proliferation of genetic information. First, is simply the lack of complete information, even in the hands of the experts, with respect to the ultimate success or predictability of many of the new applications of science. Uncertainty will always create unease and skepticism for a significant subset of people. Second, the way in which the public-that is, anyone who is not a scientific expert-views a particular issue will depend on the information available and how it is presented. As will be discussed later, the media, through which most public knowledge of new developments has been obtained, have not always behaved in a publicly responsible manner. Third, there are segments of the public that believe strongly in particular ideologies, which may be threatened both by new levels of knowledge and understanding, or by new technologies (e.g. the opposition to abortion and fetal research by the religious Right).
What then is "the public", and who speaks for it? In too many discussions on the safety and ethics of applying new technologies, the "public" is treated as a single entity with a single mind and set of attributed views, as, unfortunately, are "scientists", "industry", "government," and the other components of this highly heterogeneous collection of human institutions. There are some activist and special interest groups that represent blocs of constituents within the greater "public", many of these lobbying for directed research to develop new methods of prevention and treatment for specific diseases; others strive to protect the public from perceived harm, especially by defending them against the development and use of potentially harmful technologies promoted by profit-minded industries. Still others, and often the most powerful, are groups that proselytize a particular religious doctrine, which they interpret to preclude certain practices or uses of technology.
Hence, since the first demonstrations that genetic material could be functionally combined from two unrelated organisms in the early 1970s, genetic research and technology has been steeped in controversy. There were initially strident critics calling for a total ban on any such methods, or at least very strict containment regulations. As the recombinant DNA techniques that triggered the first wave of fears proved to be quite safe through years of widespread use, the focus of public critics has moved on to the expanding frontiers of cell biology and genetic technologies. There have been waves of opposition to in vitro fertilization, and then to somatic cell gene therapy, and now there is rather intense opposition to human germline gene therapy, while the techniques continue to be refined in animal models. Some countries (e.g. Germany) have even passed laws against human germline modification. At present, the prospects of cloning exact genetic copies of animals, and maybe humans, has set loose another barrage of opposition, and most recently, the ability to culture pleuripotent human embryonic stem cells, 2 capable of regenerating specific organs or tissues, or even perhaps a whole human being, are the focus a new round of concerns. A furor over whether or not stem cell research is included in a ban on the use of federal funds to support research on human embryo tissue in the United States (the result of lobbying by anti-abortion groups), led to a petition to President Clinton and the U.S. Congress from a large group of U.S. Nobel laureates stating that there would be "serious negative consequences" of not allowing such research to proceed.
In any case, the necessity for the pharmaceutical and biological industries, as well as the genetic counselor and practicing physician, to be fully accountable for providing benefits to the consumers, and not subjecting them to unacceptable or unknown risks, is self-evident and beyond debate. However, the above discussion leads naturally to public concerns that transcend matters of safety and efficacy. The concerns raised are virtually always in opposition to the use of new technologies. And whether or not these have a sound basis, they are nevertheless the very real fears and worries of the public-both the consumers and the greater public-who will be affected, both directly and indirectly, by the new wealth of genetic information. Therefore, the companies, scientists, and physicians who have made possible the explosion of genetic data and their corollary applications have a responsibility to acknowledge and deal with these concerns.
There are a number of different kinds of worries and concerns that have been expressed, as arguments for not proceeding at all with, for example, germline intervention, and especially if used for enhancement purposes, as well as with applications of the use of genetic data and of methods in cell biology (e.g. cloning). It is useful to discuss at least some of the major issues briefly here.
Genetic determinism and the reductionist view of humanity
The emerging view that every aspect of a human being can perhaps be described and predicted solely from the content of his or her genes is posing a major challenge to the traditional concepts of humanity, and what it means to be human. This challenge is broad, attacking cherished and traditional views ranging from religion to theories of education, and posing the proposition that the determinism inherent in the genes encompasses the entire beings of all living things.
It is very unnerving to many that we are now, so it seems at least, on the threshold of being able to see the entire set of architectural plans and schematic diagrams for the structure and function of every human being. Such an individual genetic analysis, some promise, would be able to predict an individual's physical attributes, the competence of their immune system, inborn genetically-based deficiencies, and, ultimately, of course, a person's intellect, and perhaps even his personality, and character. For many, cracking the code, not only for individual genetic messages coding for particular proteins, but for the higher levels of information and organization ultimately specified in the genome that contain a highly detailed program of who you are and how you will function, and even how the expression of your genes responds to your total environment, represents unacceptable reductionism. It flies in the face of the traditional concepts of the sanctity of the human soul and spirit, with consciousness seen as something that transcends even the most intricate and hierarchical levels of molecular organization. 3 Behavioral genetics, 4 at first greeted with hostility and dismissed by many as nonsense because it threatened the wisely accepted behaviorist mindset, is now well entrenched. The genetic bases for many psychiatric disorders, intelligence, and other aspects of behavior are slowly emerging. But where is the boundary between inherited behavior and learned behavior? Are there, for example, born criminals? Sociopaths? How much do character, temperament, integrity, self-confidence, altruism, and the capacity to be empathetic and loving derive from genetic determinants, the products of millennia of evolution, and how much is learned? The observation that unsettles many as our knowledge expands is that the growing importance of genetics, and at least the wealth of information forthcoming from the efforts to map and sequence the human genome, will allow us to answer these questions.
While it is a fact that we are all genetically different, it is curious that it has been assumed that the distribution of genetically determined traits and abilities among people in all of the global population groups is essentially identical. Our commitment to uniform social justice and equality of all ethnic and racial groups is easier to defend if this assumption is valid. Indeed, such an assumption has practically acquired the status of doctrine, not to be questioned. However, what if genetic data emerging from isolated populations in different geographical areas reveal that there are significant differences in the distribution of gene frequencies? More recently, DNA analysis of members of Indian castes revealed that the virtual absence of mixing among the castes for many centuries makes it possible to tell the caste of an individual from a DNA "fingerprint." Whether these differences are merely trivial or translate into some phenotypic difference remains to be seen. However, such data demonstrate that population isolation, even within the same society, is reflected in the genes. The null hypothesis demands that all of these differences are probably not trivial.
The concept of gender equality, or rather functional equivalence in abilities based in the central nervous system, a cornerstone assumption of many feminists, has also been undermined by the new genetics. While nobody disputes than men and women, or boys and girls, are fundamentally different, the evidence for fundamental differences in the expression of certain gene families between males and females relating to brain development is becoming well documented. This phenomenon results from the significantly higher levels of testosterone produced by male fetuses during a critical period in development, affecting the development of certain features of the central nervous system early in life, leading to demonstrable differences in both the structure and function of male and female brains.
While the fundamental importance of genetics continues to be strengthened, data are also accumulating on just how the environment influences individual development, and the central nervous system in particular. Thus while the ideology that it's not in our genes 5 can no longer withstand the weight of genetic data, it is unlikely to be replaced by a counter-doctrine that states that it is all in our genes. Clearly this is not the case. It has long been known from animal experiments, that certain accessible features of the central nervous system, notably the visual cortex, would not develop properly unless young animals were given the full range of visual stimulation very early in life, just as it is known that humans with severe optical defects never develop full use of an eye even when the optical problem is fully corrected, except in the rare instances where the defect is diagnosed nearly at birth. There is also a mounting body of animal data that demonstrates the critical role of environmental stimulation in the proper development and "hard wiring" of the central nervous system. Consistent with these observations are controlled studies on very young children of low-IQ mothers which show dramatic differences in IQ of children given intensive mental stimulation and the control groups given only normal day care, the magnitude of the difference and how long it persisted depending on the length of the period over which such stimulation was given. 6 The way in which environmental stimuli influence genetic expression during critical periods for development and beyond are themselves very likely to be determined genetically.
Thus we find ourselves at yet another major transition point in history where an adjustment of prevailing worldviews and their underlying ideologies is necessary. We can look back easily to the plight of Galileo Galilei whose heretical insight was denounced by the church-then the caretakers of the public's views of humanity and the ways people were to view themselves in the universe. In this historical context, it is easy to denounce such inability to accept a contrary view of nature, and to recognize the oppressive power of cherished and even officially enshrined views of nature. At that time, giving up the idea of the central nature of the earth in the scheme of things was simply going too far outside of any acceptable construct of the universe.
And much more recently, as science began to close in on the nature of man, the reception of Darwin's views was nearly as harsh at that encountered by Galileo. There are still those who cannot bear to part with the comforting view of a divine creator and of some unique and special place for the human being, the well-established process of evolution notwithstanding and in spite of the fact that humans bear 98 per cent genetic homology to gorillas.
The Lysenko era in the Soviet Union, set back genetics for decades simply because the emerging understanding of the transmission of genetic traits was at odds with dialectical materialism, which demanded that acquired traits be heritable. But it is less easy to be objective about oneself. Many will part with extreme reluctance with the doctrine that cognitive traits are primarily determined by the environment, a view held as a truism today, because theories of social justice and racial and ethnic equally demand that it be so.
Deliberate misuse of genetic data
Since the successful cloning of a sheep was announced, 7 an irrational wave of fear arose that humans might be cloned. Why was this thought so scary? Few asked why one would wish to clone an adult to make an exact genetic replica of a particular person in the first place. 8 And if they did, so what? Would a clone of Mozart, growing up in the year 2000 in the United States, be able to compete with all of the talented young musicians? What path would a clone of Hitler follow in an environment that differed dramatically from Germany in the 1920s? Would a clone of Einstein be able to get into Harvard? Yet fictional scenarios, like the Boys from Brazil, a movie where the long hidden Dr. Mengele emerges to reveal that he has successfully cloned some 37 exact genetic copies of Adolf Hitler, seem to strike terror into the hearts of many.
There was such a furor and a reaction to the news of Dolly the cloned sheep that President Clinton in the United States gave an executive order to prohibit the use of Federal funds for any human cloning. Similar edicts appeared in Europe. The scientific community, in general, thought the ban not only unnecessary, but saw it as caving in to fearsome and uninformed critics. Indeed, there are legitimate questions of safety that might establish a sound scientific basis for not propagating humans through cloning, such the accumulation of genetic errors in the nucleus of an adult somatic cell, and the fact that the technique at present works less than 1 per cent of the time. 9 But such safety questions were not a major part of the presidential decision. Here then, is a lesson that is highly relevant to this topic.
Other fear scenarios that emerge are the deliberate, state-sanctioned creation of soldiers, enhanced for aggressiveness. Or the creation of a super-strong, super-intelligent, and no doubt super-ruthless ruling elite that would enslave the rest of us. The seeds of such fear are always traceable to actual events in our recent history, where the acts of tyrants without the tools of the new genetics have been and continue to be horrible enough. And just as the extensive and intimate knowledge of infectious agents becomes available, as well as the master plan of human structure and function, the dread of novel and totally hideous biological weapons has also emerged. As the power of knowledge increases, the means to put it to misuse no longer require large expensive secret facilities, but become within the reach of many, generating a feeling that there is no safe haven from the perpetration of terror. Indeed, there probably isn't.
Another important area that has raised concerns is the matter of privacy. If there is to be routine, detailed genetic fingerprinting of all citizens, admittedly a useful body of data in predicting health status and disease susceptibility, is there a possibility that such data could be used by others as a basis for discrimination? That is, if certain traits indicated a potential health risk, or a deficiency in some desirable skill, access to genetic data could be used, potentially, for job discrimination or in denying health or life insurance. How could the privacy of such data be protected?
There are always those whose fears of misuse of new knowledge provoke calls for limitations on knowledge or scientific inquiry itself. That is, the concept of "forbidden knowledge" rises once again. The idea of forbidden knowledge has been around since the story of Adam and Eve, and has surfaced with regularity since in many diverse forms. Even today, there are those who are disturbed about investigation into the essence of human life that the new genetics makes possible. Or who say that we should not investigate areas that may uncover understanding that threatens cherished religious doctrines or ideologies. The fallacy is obviously that any knowledge can be applied in both beneficial and destructive ways. This is yet another instance where the challenge to society is not to prevent wrongdoing and calamity by perpetrating a scientific "know nothingism", but rather to strengthen our social and political institutions to keep those who would be feared under control. This is a topic of major importance, but which is well beyond the scope of this essay.
Fairness and distributive justice
Fairness is one of the predominant public concerns that has been raised with respect all forms of gene therapy, but especially with respect to the application of any technology that aims to improve the outcome of procreation. As has been discussed above, an obvious corollary of the elucidation of a complete genetic map of the human being, including the eventual understanding of the function of genes and gene products, and how they interact to produce a particular phenotype, is the ability to select certain characteristics at the time of conception. The transition from germline therapy-the correction of genes carrying known pathology-to a selection for optimum function, whether physical, neurological, or psychological, is not a clearly defined boundary.
Anticipating the emergence of genetic enhancement services, now frightening for most, we can expect in time that the public will accept, at least in principle, that it is OK for prospective parents to select positive traits they desire in their children. If the option existed, and safety were guaranteed, would most prospective parents still prefer to roll the genetic dice or to be certain of a positive outcome. If history is any guide, one would anticipate a significant number of people, when given the choice, to want all of their children to be well-endowed.
However, it is certain that, at least in the beginning, such services will be expensive and not available to everyone. As such, even if there is general acceptability on ethical grounds, it is unlikely that health insurers or state supported healthcare systems would cover a service not directly related to health. Hence, the concerns of fairness and its implications.
If only a wealthy subset of the population in any country can afford such enhancement services, there is the fear that the superior children so produced may be the beginning of elite genetically based dynasties, that only exacerbate class stratification and socioeconomic discrepancies. Some have asserted that this has already happened, at least in the United States, 10 simply because the more able people tend to earn more money and enjoy a higher standard of living, and because they marry and procreate within their own class. But if such services are not universally available, such a polarization is inevitable. Thus the fear of societies more sharply divided than at present, not simply on the basis of social and economic class, but through planned genetic superiority, poses a major policy challenge. It is here where the hierarchy of the human values of individual autonomy and social justice may be in sharp conflict.
Since distributive justice in healthcare has still not been achieved in many countries, most notably in the United States, it is unlikely that it will come about at least in the relatively near future with respect to an expensive and non-essential procedure. Far more divisive than the injustice of unequal standards in healthcare delivery would be unequal privileges with respect to the distribution of intrinsic gifts for one's children. The fairness doctrine would demand that if such privileges are not available for everyone, then they should not be available to anyone.
Eugenics-improving the odds of having more gifted children through selective matingwas practiced as an organized movement in the early part of the twentieth century. 11 While the principle of "good breeding" would seem innocent enough, and is an acknowledged consideration in marriage throughout the world, eugenics, as a defined movement, acquired a very bad name, not only because of the elitist and racist views of some if its proponents, but through the abuses and claims of the Nazis, with the goal of producing a dominant and superior master race. It is no doubt this latter association that essentially removes any modern-day discussion of eugenics from serious consideration. Yet the techniques of gene enhancement are essentially aimed at the same goals but through a much more precise and well-defined method. There is still a lingering abhorrence of any practice resembling eugenics, fearing that it could be state sanctioned and promote severe discrimination against the genetic have-nots.
If such practices were left entirely up to the individuals, but were available to only a wealthy subset of people, then the eventual results are feared to be not a great deal different than the outcome of a modern eugenics program promoted by a despot. However, is it even remotely realistic to think that such gene selection services would ever become so routine and inexpensive that they would be available to all? At present this would not appear to be a feasible option, but we continue to be amazed at the rate of technological advances, so we should never rule out the possibility.
In the event that such procedures become easy, inexpensive, and universally available in economically advanced countries, the world will then face the prospect of a new kind of racism. Reproduction in poor countries would still take place by the old fashioned methods, while high-tech genetic manipulation would be available to those in "developed" countries. If there is uncertainty now about whether or not there are innate differences in average cognitive abilities between peoples from different parts of the world, the skewed application of universal reproductive enhancement will guarantee that there soon will be. This is not a situation likely to improve the existing problems that now exist with respect to racial and ethnic conflicts around the world.
The mistrust of science, scientists and the biotechnology industry
While society depends on and ultimately embraces the advancements of science and technology in essentially every aspect of life, there is an undercurrent of suspicion and mistrust of science that is a factor in the shaping of public opinion. It is not universal, and the origins of this feeling are difficult to pin down and define. No doubt it comes from several sources.
First of all, the pharmaceutical industry, especially the giant companies that promote aggressively the extensive use of all sorts of remedies and substances that are not necessarily in the public interest, does not have an unblemished record of ethical conduct. As a partner in the promotion and selling of the new pharmaceuticals based on the new genetic data, the pharmaceutical giants are viewed by many with suspicion and seen as being in it only for the money. A corollary of this gnawing unrest is the feeling that perhaps the companies may not be completely forthcoming about the safety and efficacy they claim for their products, even if they have been approved by the FDA. There are enough drugs that have had to be withdrawn from the market after the long-term effects became clear. Watchdog organizations, such as the Health Research Group of Public Citizens, headed by Dr. Sidney Wolfe (the recent recipient of a prestigious MacArthur Foundation award), generate numerous reports to the press on the alleged misuse of certain pharmaceuticals, suppressed reports of side effects, etc. They have turned out to be right enough times to help cast a pall of doubt on the credibility of the pharmaceutical industry generally.
The biotechnology industry, while much of it does engage in developing products for the healthcare industry, is much more involved in contributing to the explosion of genomics data and the applications thereof than "big pharma". However, for the past 20 years, the industry has been in a somewhat defensive position, trying to make its case for the continuous stream of novel applications of genetic manipulation and innovations in immunology and cell biology in the face of doubt arising from both public uneasiness over new technology and strident critics who seem to be against everything. For example, the sale of transgenic crop plants, designed to resist certain pests or plant pathogens, has been subjected to extensive opposition but virtually none of it is based on any specific tangible factual problem. Rather just the idea of eating something that has been genetically manipulated per se is scary to many people, a perception not helped when newspaper reports refer to "Frankenstein foods." By their own admission, the companies developing transgenic crop plants were caught unprepared.
There is a prevailing suspicion held by many that somehow, the companies are trying to put one over on the people, in the interests of profit, and if there is a known risk, they are careful not to tell. Most companies, of course, whether multinationals or entrepreneurial start-ups, if anything, err far on the side of safety; and their products are subject to stringent regulations anyway. But the few isolated cases where companies have engaged in ethically questionable practices have been sufficient to taint the industry. Unfortunately, the biotech industry generally has been slow to be pro-active in presenting its case in an upbeat way to the public. Companies that wait until they are under attack, and then find themselves in a very defensive position, have lost an important opportunity and their credibility inevitably suffers.
To add to public doubts are commentators who cry "foul" when companies are commercializing and making profits on discoveries that were originally made under research grants made possible from public tax revenues. The argument, simplistically stated, is that the public already paid for the science providing the discovery. Why should the public then have to pay a private company or a for-profit medical care provider outrageous sums simply to benefit from the fruits of research that they have already paid for? What such arguments don't explain is that the costs of development and testing of any pharmaceutical or vaccine are many times higher that the original research funding that enabled the discovery in the first place. Such criticisms have certainly arisen with respect to the generation of genomic data, much of it publicly funded. Genomics companies promise their investors high returns on their investments, and so sell or license their information to the highest bidders. Not infrequently, however, similar data are being generated by both public and other private funding. The patenting of genomic data is very unclear at present, but there is a general recognition that the simple description of base sequence data is insufficient for proper patent protection. One must show the utility of a particular gene or genomic region in order to obtain a patent on specific DNA sequences and an application enabled by that structure. Nevertheless, to develop any genetic data into a useful product or service requires the investment of sums that greatly exceed the costs of discovery. In a capitalist economy, where development costs and the risks are assumed by private investors, they must be able to realize a profit. Otherwise, there would simply be no investment to develop the novel genetic technologies into useful products and services and the public would never realize the benefits.
The public image of the scientist is also tarnished. Not by everyone of course, but by a significant number. Why is that? Too many science fiction movies and TV series perhaps, where scientists, particularly corporate scientists, are either evil, mad, or totally co-opted by the money? Of course such perceptions are hardly universal, but Jurassic Park, for example, while most saw it as fun entertainment, probably did not help the image of either the scientist or the biotechnology industry. This takes us to the important topic of the role of the media.
The media and the public understanding of science
To return to a point made early in this essay, public opinion is influenced to a large degree by how information concerning new scientific discoveries or new technological developments is presented. Unfortunately, much of the initial route by which the public has gained information about the revolution in genetics and molecular biology, beginning in the early 1970s, has been in the form of what one commentator 12 calls "genetic pornography," that is "reports dressed up to titillate and frighten."
When the cloning of Dolly the sheep was discussed on the front page of the Sunday New York Times in February 1997, I happened to be driving in San Francisco and had the car radio tuned to the independent Pacifica station, KPFA, which for many years has had a Sunday morning program that begins with nice renaissance or baroque music and ends with a synopsis and often cynical commentary of the front page articles in the New York Times ("All the news that's fit to spit"). On this particular day, the hottest news item-Dolly-was saved for last. The program's host began by saying in very expressive terms that he was totally terrified by the news that an animal could be cloned! He went on to describe, quite incorrectly, how he thought cloning was carried out. Then he invited people to call in with their comments. After a great deal of misinformation about the techniques of cloning was bandied about, along with all the standard scare scenarios about cloning humans, some graduate student called in to straighten them out, but even he didn't have it completely right.
This episode impressed upon me once again that the public is really very often led astray by science reporting. In this case, the New York Times article was actually fairly neutral and reasonably accurate, based on a report in Nature, 13 but the interpretation of the KPFA commentator presented a far more alarming view of this milestone scientific achievement. In the early days of gene splicing, an article appeared in the New York Times Magazine as the cover story entitled New Strains of Life-or Death, 14 that was full of scare scenarios that aroused the fears of Senator Ted Kennedy sufficiently to hold a public hearing on the subject. Although the author had all of the right scientific credentials to be credible to the public, within the scientific community, his views were considered sadly misguided. But neither the public nor Ted Kennedy knew that.
The New York Times is the top of the line when it comes to newspapers. Therefore, one should be able to believe what one reads there, right? Unfortunately, the New York Times Magazine, as with other publications directed toward educated readers (e.g. Atlantic Monthly, the Nation, the New Yorker) often publish articles about science or technology that are interesting and seem to be presenting a case for a new revelation that the public may not have been aware of. Unfortunately, the editorial staff of these publications do not subject such articles to scientific peer review and do not have the in-house expertise to judge the validity of the arguments themselves. Accordingly a lot of things are published and influence public opinion that are often simply one of the perennial critics grinding his axe in yet another forum. A case in point was an article by the perennial critic of biotechnology, Jeremy Rifkin, which appeared in the Nation in early 1998. 15 It was familiar rhetoric, and I had friends calling me alerting me to the terrible problems this scholar had revealed! While I do not wish to suggest that none of the issues raised were legitimate topics for discussion, the style in which they were introduced was clearly calculated to arouse public fears rather than to present an unbiased account of the facts and realistic prospects.
Television, however, can, by its sheer presence in virtually every home, exert a much more powerful force on the shaping of public opinion than the printed word. Thus it is capable of enlightening, or misleading, great numbers of people, depending on the responsibility with which it is used. My first direct encounter with the true driving force of this powerful branch of the communications media occurred in the mid 1970s. The producer of a segment of Good Morning America told me before I participated in a debate she was arranging on the safety of gene splicing, "We don't want you to be calm and rational. We want you to yell and scream at each other. This is show biz." My experiences with local TV have been even worse. Once in the mid 1980s while being interviewed by a local San Francisco station for the evening news, against the mandatory laboratory backdrop, about the then new development of creating transgenic animals and the possibility of so transforming humans, I recall describing the methods and saying that it "had already be done in animals." When the segment aired, they showed only a few seconds of my tweedy professorial image before cutting away to scenes from an old Frankenstein movie, over the background beat of a suspenseful soundtrack. My voice was still there, but then they deleted "in animals" from the end of my sentence to make it sound as though we were already making transgenic humans.
It is no wonder then that the lay public, one that in general does not have ready access to the original scientific reports or the training to understand them, only has its fears reinforced by an all too common type of news reporting that endeavors to sensationalize and emphasize the scary side of virtually everything it can. The viewers are not supposed to think and ponder a subject and draw their own conclusions. They are rather to be entertained in their short attention span for any particular topic, so they won't get bored and switch channels. This only promotes the public misunderstanding of science.
Fortunately, amid the hard sell of commercial television, there are numerous science education programs that are accurate, fair, informative, and very competently made. The NOVA series by WGBH and PBS is an excellent example of the proper use of the power of the visual medium of television to inform and educate the non-specialist. The BBC series entitled The Human Body is another example a highly informative and accurate TV production. Moreover I have participated in panels and debates on controversial issues in bioethics for National Public Radio and the Voice of America that were handled in a very professional and responsible manner. The science and technology segments on NPR that Ira Flatow has been creating for more than 20 years have always been accurate, responsibly presented, and-counter to the way science is perceived by many-interesting. The overall effect of such programs is of course a function of the size and composition of the audience. The ratings speak for themselves-the vast majority of people everywhere seem to prefer commercial TV.
Scientific literacy and science education
If indeed it is true that public opinion regarding the new genetics is largely influenced by the genetic pornography of the less responsible segments of the media, what can be done to ensure that the public knows enough about science to be immune from attempts to sensationalize it? The pitch for science education has been made in numerous forums. It is a valid need for all segments of society, and it must begin early in life. In our increasingly technical society, run by high-tech computer and telecommunications technology, and highly sophisticated medicine, understanding the basics of science and technology is a must for everyone.
However, there are different levels of scientific literacy. To be sure, everyone cannot be expected to have the wealth of knowledge and experience of an expert in every field that would permit an independent evaluation and judgment of the social effects of every new discovery and development. Even to achieve a level where most people could read easily every article in Scientific American is quite unrealistic. What can be achieved, however, is a sufficient level of knowledge about basic biology and physics, and an understanding of the scientific method to the extent that one can understand the difference between a hypothesis and a fact, and the distinction between anecdotal observations and experimental validation. Critical reading and viewing, with a measure of skepticism, is healthy.
The conundrum that we are faced with today, however, is that those charged with making policy decisions with respect to new and complex scientific and technical issues, which include most members of national parliaments or the U.S. Congress, can't begin to understand the most elementary aspects of risk assessment, or genetics or electronics or space exploration. But still they are expected to make informed decisions that concern all of us. Hence, we live in a day of expert advisors in our political systems. But, as is often pointed out in professional journals, politics wins over expertise every time, as in the U.S. ban on human cloning.
There will always be controversy surrounding the introduction of any new technologies and medical interventions, and especially ones that represent major departures from our comfortable worldviews. Public dialogues over the safety, efficacy, long-term effects on population and the environment, and on society should be seen as constructive in the long run. However, it is important that the discussions take place in a rational and balanced forum, with the participants well informed and their motives clearly revealed. In the present day, where public opinion, especially with respect to new scientific and technological developments is strongly influenced by the media, and to a lesser degree by the ability of both social critics and vested interests to present their case effectively, the attempt to formulate uniform and rational policies across and within national and regional boundaries seems chaotic. The implications of the continuing revolution in genetic technologies and the collection and interpretation of genetic data are only slowly becoming appreciated by the public, public servants, and even the instigators of the revolution themselves.
Here, then, we must recognize a responsibility of the professionals that goes beyond ensuring efficacy and safety and both personal and corporate ethical conduct. It is incumbent upon those developing and promoting new technologies to take the lead in presenting their case to the public. Openness, complete honesty, and an obvious willingness to engage in a dialogue with the public constituents and critics could do much to dispel the impression that companies are off operating in high secrecy and not letting people in on all the consequences they have in store for them. Every company knows the importance of PR. But a shift away from the hard sell to provide information that addresses the real concerns of people and is not simply designed to create a market would be a very significant and positive move. Such programs as a major element of professional and industrial societies are sorely lacking. That is, instead of appearing simply to be protecting a self-serving position, a shift toward real education and a responsive dialogue would be most welcome. This could go far to restore confidence in what is overall a very responsible industry.
Organizations such as the Pharmaceutical Manufacturers Association (PMA) and the BioIndustry Organization (BIO), for example, should be explaining to the public just what it is that the new genetic technologies can mean for the future of humanity. Readers will surely recall the deluge of PR copy on television and everywhere as the Internet was being promoted. Remember the charming voice of Anna Paquin telling you time and time again how the Information Superhighway would change your life in marvelous ways? Perhaps it is time now for some good responsible promotion of the upside of the genetic revolution. There will of course always be critics, fortunately. The downside, real and imaginary, will be widely and poignantly proclaimed. But perhaps a balanced exchange can be achieved after all.
Conclusion
There is no question that both the biotechnology industry and the medical profession accept a high degree of responsibility and accountability for the steady stream of new pharmaceuticals and intervention technologies that are developed and promoted for the general good of mankind. Indeed, they have no choice, because of the numerous professional and regulatory bodies that exist to ensure the safety and efficacy of such products and procedures.
Nevertheless, public fears, whatever their origins and however irrationally based, must be acknowledged by the professionals and a public dialogue established, so that the hesitancy to accept the new, especially the new genetics, which may require a radical change in the way people view themselves, will at least not be based on ignorance or misunderstanding, or on groundless fears.
The press and television in most countries, unfortunately, has generally fed and exacerbated the fears of new science and technology, rather than used its potential to ameliorate such fears. In addition, the handful of clever and articulate individuals who perennially oppose new technologies or espouse antiscience ideologies, are rather skilled at arousing and reinforcing the latent worries of the lay public. It is difficult enough to be confronted with an overwhelming body of arcane scientific and technological information, especially with respect to genetics, which the public is ill-equipped to analyze and evaluate without a lot of help from the experts.
The formulation of public policy with respect to issues such as genetic enhancement intervention, where competing values of individual autonomy, social harmony, and distributive justice may clash in dramatic fashion, is not an easy task for present and future societies. Accordingly, there are very important reasons now for aggressive information and education campaigns, both publicly and privately supported, to overcome the lack of accurate information and sensationalized misinformation that lie at the bottom of most fears of science and technology. However, that is not to say that there are not valid reasons for the control and limitation of technology in many and perhaps most areas. But we must be sure that such action is taken for the right reasons.
As we enter the third millennium, we are forced to acknowledge the current instability of virtually all of planet earth's systems, even if the immediate human condition is improving for the technologically privileged minority of the earth's inhabitants. If the earth is to survive even another century, as a place we would like our descendants to live and flourish, then it is critically important to take a long, unselfish view of where we are going, and understand that focusing on technological fixes in any area may be a tragic misplacement of our priorities.
It is a dilemma for those of us engaged in a scientifically exciting era, where we are rapidly learning about all the insidiously clever ways infectious agents have evolved for fooling mother nature's marvelous immune system, and using the wealth of new genetic data to invent ways to prevent and clear even the most intractable of these with a totally new concept in vaccine design. But the result is that we are only exacerbating the severe problem of overpopulation, where the human race has already grown to such numbers that it is rapidly driving the planet's co-inhabitants into extinction, and squandering its precious resources for short-term self-gratification.
Therefore, true professional responsibility demands that everyone participate not only in ensuring that a particular innovation be applied in a safe and ethical manner, but in considering how such an innovation fits into a complex system full of a multitude of other innovations, too many people, and deteriorating planetary ecosystems.
